ResMed Inc. (NYSE:RMD) Q4 2025 Earnings Call Transcript July 31, 2025
ResMed Inc. beats earnings expectations. Reported EPS is $2.55, expectations were $2.49.
Operator: Hello, and welcome to the Q4 Fiscal Year 2025 ResMed Earnings Conference Call. My name is Kevin, and I’ll be your operator for today’s call. [Operator Instructions] Also, please note this conference call is being recorded. [Operator Instructions] Let me hand the call over to Salli Schwartz, ResMed’s Chief Investor Relations...
